16-3729247-A-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004380.3(CREBBP):​c.5800T>C​(p.Ser1934Pro) variant causes a missense change. The variant allele was found at a frequency of 0.000375 in 1,526,834 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00029 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00038 ( 1 hom. )

Consequence

CREBBP
NM_004380.3 missense

Scores

1
6
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:2B:5

Conservation

PhyloP100: 5.09

Publications

7 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.056996673).
BP6
Variant 16-3729247-A-G is Benign according to our data. Variant chr16-3729247-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 158387.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000293 (44/150386) while in subpopulation NFE AF = 0.000548 (37/67498). AF 95% confidence interval is 0.000408. There are 0 homozygotes in GnomAd4. There are 22 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 44 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
NM_004380.3
MANE Select
c.5800T>Cp.Ser1934Pro
missense
Exon 31 of 31NP_004371.2Q92793-1
CREBBP
NM_001079846.1
c.5686T>Cp.Ser1896Pro
missense
Exon 30 of 30NP_001073315.1Q92793-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
ENST00000262367.10
TSL:1 MANE Select
c.5800T>Cp.Ser1934Pro
missense
Exon 31 of 31ENSP00000262367.5Q92793-1
CREBBP
ENST00000382070.7
TSL:1
c.5686T>Cp.Ser1896Pro
missense
Exon 30 of 30ENSP00000371502.3Q92793-2

Frequencies

GnomAD3 genomes
AF:
0.000299
AC:
45
AN:
150270
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000492
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000660
Gnomad ASJ
AF:
0.000867
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000548
Gnomad OTH
AF:
0.000484
GnomAD2 exomes
AF:
0.000350
AC:
46
AN:
131462
AF XY:
0.000323
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000410
Gnomad ASJ exome
AF:
0.00103
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000715
Gnomad OTH exome
AF:
0.000249
GnomAD4 exome
AF:
0.000384
AC:
528
AN:
1376448
Hom.:
1
Cov.:
35
AF XY:
0.000373
AC XY:
253
AN XY:
678226
show subpopulations
African (AFR)
AF:
0.0000637
AC:
2
AN:
31406
American (AMR)
AF:
0.000169
AC:
6
AN:
35522
Ashkenazi Jewish (ASJ)
AF:
0.00141
AC:
35
AN:
24798
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35618
South Asian (SAS)
AF:
0.000102
AC:
8
AN:
78612
European-Finnish (FIN)
AF:
0.0000583
AC:
2
AN:
34292
Middle Eastern (MID)
AF:
0.00145
AC:
6
AN:
4152
European-Non Finnish (NFE)
AF:
0.000418
AC:
449
AN:
1074618
Other (OTH)
AF:
0.000348
AC:
20
AN:
57430
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000293
AC:
44
AN:
150386
Hom.:
0
Cov.:
32
AF XY:
0.000300
AC XY:
22
AN XY:
73396
show subpopulations
African (AFR)
AF:
0.0000491
AC:
2
AN:
40758
American (AMR)
AF:
0.0000659
AC:
1
AN:
15174
Ashkenazi Jewish (ASJ)
AF:
0.000867
AC:
3
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5056
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4762
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10384
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000548
AC:
37
AN:
67498
Other (OTH)
AF:
0.000478
AC:
1
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000941
Hom.:
0
Bravo
AF:
0.000423
ExAC
AF:
0.0000709
AC:
6

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
-
1
CREBBP-related disorder (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Rubinstein-Taybi syndrome (1)
-
1
-
Rubinstein-Taybi syndrome due to CREBBP mutations (1)
1
-
-
Tip-toe gait (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Uncertain
0.069
T
BayesDel_noAF
Pathogenic
0.23
CADD
Benign
21
DANN
Benign
0.94
DEOGEN2
Uncertain
0.53
D
Eigen
Benign
-0.14
Eigen_PC
Benign
0.041
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.79
T
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.057
T
MetaSVM
Benign
-0.41
T
MutationAssessor
Benign
0.95
L
PhyloP100
5.1
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-1.6
N
REVEL
Uncertain
0.48
Sift
Benign
0.068
T
Sift4G
Benign
0.24
T
Polyphen
0.014
B
Vest4
0.10
MVP
0.99
MPC
1.6
ClinPred
0.056
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.37
gMVP
0.20
Mutation Taster
=69/31
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587783504; hg19: chr16-3779248; COSMIC: COSV105864154; COSMIC: COSV105864154; API